ProCE Banner Activity

Rationale for Targeting NTRK Fusions in Head and Neck Cancers: Slides

Slideset Download
Downloadable slides to review the rationale for treating NTRK fusions in patients with head and neck cancer.

Released: December 21, 2020

Expiration: December 20, 2021

No longer available for credit.

Share

Faculty

Aarti Bhatia

Aarti Bhatia, MD, MPH

Assistant Professor
Division of Medical Oncology
Department of Internal Medicine
Yale Cancer Center
New Haven, Connecticut

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Bayer Healthcare Pharma

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Aarti Bhatia, MD, MPH

Assistant Professor
Division of Medical Oncology
Department of Internal Medicine
Yale Cancer Center
New Haven, Connecticut